[ORGANIZATION]
DualityBio
Featured in 2 tracked stories · first seen
Situations
Moderna and Merck melanoma vaccine clinical trials
19 clusters · 558 sources · last updated
Latest: BioNTech and Moderna face mixed clinical and market outlooks
Moderna and Merck (MSD) have reported positive Phase 3 clinical trial results for intismeran autogene (V940), an experimental personalized mRNA cancer vaccine. The INTerpath-001 trial, which administered the vaccine alon
Also covered in
-
Immunotherapy combinations show promise in treating refractory solid tumors
[HEALTH] · 2 sources ·